Pfizer Limited (BOM:500680)

Pfizer Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	1,027	4,951	1,120	366	627.6
Short-Term Investments	-	29,857	22,876	19,153	18,118	15,705
Cash & Short-Term Investments	30,884	30,884	27,826	20,273	18,484	16,332
Cash Growth	10.99%	10.99%	37.26%	9.68%	13.17%	47.62%
Accounts Receivable	-	1,818	1,931	1,876	1,517	1,426
Other Receivables	-	179.8	209.4	514.4	403.4	874.6
Receivables	-	1,998	2,140	2,391	1,921	2,303
Inventory	-	4,727	4,759	4,337	4,177	4,489
Prepaid Expenses	-	80.4	89.2	80.1	70.4	72.8
Restricted Cash	-	37.8	29.8	45.9	39	74.8
Other Current Assets	-	305.7	283.7	569.5	560.2	342.7
Total Current Assets	-	38,032	35,129	27,696	25,251	23,614
Property, Plant & Equipment	-	1,561	1,795	1,514	1,855	2,201
Goodwill	-	5,275	5,275	5,275	5,275	5,275
Other Intangible Assets	-	143.5	243.1	342.7	442.3	945.5
Long-Term Deferred Tax Assets	-	723.1	693	539.4	976.7	469.8
Other Long-Term Assets	-	3,484	5,977	6,922	6,208	6,496
Total Assets	-	49,219	49,111	42,288	40,007	39,005

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	2,159	1,516	1,662	2,171	2,639
Accrued Expenses	-	734.8	662	559.3	1,258	960.3
Current Portion of Long-Term Debt	-	25	25	25	25	25
Current Portion of Leases	-	316.5	382.8	376.9	386.5	367.5
Current Income Taxes Payable	-	2,320	2,210	1,601	1,608	1,695
Current Unearned Revenue	-	51.8	38	566.3	34.8	1,795
Other Current Liabilities	-	667.6	861.7	675.3	1,090	1,048
Total Current Liabilities	-	6,275	5,695	5,466	6,574	8,529
Long-Term Leases	-	360.8	676.2	543.5	933.2	1,277
Pension & Post-Retirement Benefits	-	-	-	-	-	56.1
Other Long-Term Liabilities	-	554.2	565.7	323.3	427.6	498.6
Total Liabilities	-	7,190	6,937	6,332	7,934	10,361

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	457.5	457.5	457.5	457.5	457.5
Additional Paid-In Capital	-	13,207	13,207	13,207	13,207	13,207
Retained Earnings	-	27,054	27,378	21,303	17,620	14,354
Comprehensive Income & Other	-	1,311	1,132	988.1	789.1	626
Shareholders' Equity	42,029	42,029	42,174	35,955	32,073	28,644
Total Liabilities & Equity	-	49,219	49,111	42,288	40,007	39,005

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	702.3	702.3	1,084	945.4	1,345	1,670
Net Cash (Debt)	30,182	30,182	26,742	19,327	17,139	14,663
Net Cash Growth	12.86%	12.86%	38.37%	12.77%	16.89%	47.41%
Net Cash Per Share	659.74	659.74	584.56	422.48	374.62	320.49
Filing Date Shares Outstanding	45.75	45.75	45.75	45.75	45.75	45.75
Total Common Shares Outstanding	45.75	45.75	45.75	45.75	45.75	45.75
Working Capital	-	31,757	29,433	22,230	18,677	15,086
Book Value Per Share	918.71	918.71	921.88	785.95	701.08	626.13
Tangible Book Value	36,611	36,611	36,656	30,338	26,356	22,424
Tangible Book Value Per Share	800.27	800.27	801.27	663.15	576.11	490.16
Buildings	-	137.2	138.2	132.6	125	125
Machinery	-	1,161	1,139	1,022	839.4	761.3
Construction In Progress	-	200	76.4	4	79.3	11.5
Leasehold Improvements	-	249	244.4	252.4	307.6	307.7

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error